BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12393527)

  • 1. Stem cell factor increases the expression of FLIP that inhibits IFNgamma -induced apoptosis in human erythroid progenitor cells.
    Chung IJ; Dai C; Krantz SB
    Blood; 2003 Feb; 101(4):1324-8. PubMed ID: 12393527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells.
    Dai C; Krantz SB
    Blood; 1999 May; 93(10):3309-16. PubMed ID: 10233883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
    Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G
    Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
    Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
    J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis.
    Dai CH; Price JO; Brunner T; Krantz SB
    Blood; 1998 Feb; 91(4):1235-42. PubMed ID: 9454753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes.
    Wosik K; Becher B; Ezman A; Nalbantoglu J; Antel JP
    Glia; 2001 Mar; 33(3):217-24. PubMed ID: 11241739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis.
    Hyer ML; Sudarshan S; Kim Y; Reed JC; Dong JY; Schwartz DA; Norris JS
    Cancer Biol Ther; 2002; 1(4):401-6. PubMed ID: 12432255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
    Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
    J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition of apoptotic resistant vascular smooth muscle cells to troptotic sensitive state is correlated with downregulation of c-FLIP.
    Imanishi T; Hano T; Nishio I; Liles WC; Schwartz SM; Han DK
    J Vasc Res; 2000; 37(6):523-31. PubMed ID: 11146406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex.
    Micheau O; Thome M; Schneider P; Holler N; Tschopp J; Nicholson DW; Briand C; Grütter MG
    J Biol Chem; 2002 Nov; 277(47):45162-71. PubMed ID: 12215447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein.
    Xiao CW; Yan X; Li Y; Reddy SA; Tsang BK
    Endocrinology; 2003 Feb; 144(2):623-30. PubMed ID: 12538625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell factor prevents Fas-mediated apoptosis of human erythroid precursor cells with Src-family kinase dependency.
    Nishio M; Oda A; Koizumi K; Satoh I; Sato Y; Endoh T; Tsutsumi A; Fujihara M; Ikebuchi K; Ikeda H; Koike T; Sawada KI
    Exp Hematol; 2001 Jan; 29(1):19-29. PubMed ID: 11164102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells.
    Shah S; Sylvester PW
    Exp Biol Med (Maywood); 2004 Sep; 229(8):745-55. PubMed ID: 15337828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.
    Kim H; Whartenby KA; Georgantas RW; Wingard J; Civin CI
    Stem Cells; 2002; 20(2):174-82. PubMed ID: 11897874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells.
    Yang BF; Xiao C; Roa WH; Krammer PH; Hao C
    J Biol Chem; 2003 Feb; 278(9):7043-50. PubMed ID: 12496285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
    Poulaki V; Mitsiades N; Romero ME; Tsokos M
    Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells.
    Taniguchi S; Dai CH; Price JO; Krantz SB
    Blood; 1997 Sep; 90(6):2244-52. PubMed ID: 9310475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.